Your browser doesn't support javascript.
loading
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Hashimoto, Masayuki; Nagata, Noriyo; Homma, Tomoyuki; Maeda, Hiroki; Dohi, Keiji; Seki, Naomi M; Yoshihara, Ken; Iwata-Yoshikawa, Naoko; Shiwa-Sudo, Nozomi; Sakai, Yusuke; Shirakura, Masayuki; Kishida, Noriko; Arita, Tomoko; Suzuki, Yasushi; Watanabe, Shinji; Asanuma, Hideki; Sonoyama, Takuhiro; Suzuki, Tadaki; Omoto, Shinya; Hasegawa, Hideki.
Afiliación
  • Hashimoto M; Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Electronic address: masayuki.hashimoto@shionogi.co.jp.
  • Nagata N; Department of Pathology, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: nnagata@niid.go.jp.
  • Homma T; Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Electronic address: tomoyuki.honma@shionogi.co.jp.
  • Maeda H; Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Electronic address: hiroki.maeda@shionogi.co.jp.
  • Dohi K; Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Electronic address: keiji.dohi@shionogi.co.jp.
  • Seki NM; Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Electronic address: naomi.seki@shionogi.co.jp.
  • Yoshihara K; Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Electronic address: ken.yoshihara@shionogi.co.jp.
  • Iwata-Yoshikawa N; Department of Pathology, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: inok@niid.go.jp.
  • Shiwa-Sudo N; Department of Pathology, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: n-shiwa@niid.go.jp.
  • Sakai Y; Department of Pathology, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: sakaiyu@niid.go.jp.
  • Shirakura M; Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: masas@niid.go.jp.
  • Kishida N; Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: kishidan@niid.go.jp.
  • Arita T; Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: tomarita@niid.go.jp.
  • Suzuki Y; Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: yasuzuki@niid.go.jp.
  • Watanabe S; Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: sw@niid.go.jp.
  • Asanuma H; Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: asa@niid.go.jp.
  • Sonoyama T; Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Electronic address: takuhiro.sonoyama@shionogi.co.jp.
  • Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: tksuzuki@niid.go.jp.
  • Omoto S; Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Electronic address: shinya.oomoto@shionogi.co.jp.
  • Hasegawa H; Influenza Virus Research Center, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: hasegawa@niid.go.jp.
Vaccine ; 40(31): 4231-4241, 2022 07 29.
Article en En | MEDLINE | ID: mdl-35691872
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Límite: Animals Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Límite: Animals Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article